{"id":801174,"date":"2025-01-15T12:48:23","date_gmt":"2025-01-15T17:48:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/"},"modified":"2025-01-15T12:48:23","modified_gmt":"2025-01-15T17:48:23","slug":"the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/","title":{"rendered":"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Jan.  15, 2025  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of <strong>Humacyte, Inc. (NASDAQ: HUMA).<\/strong><\/p>\n<p>Shareholders who purchased shares of HUMA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sLN1IUrCXah2TvTl3VPsqkVuaA39NVzfNS8IRv17Bfl2435Hs_8LhekEokDgpZh7T2JYMcHyQkGEK4kBz8dFzjbytcVr8Miozz128rhY9jfoW5TBIpbixXf7NlpCRC2OdSPBLdutcF3LHHr6CO2uQBJbbxxzGWojgKHUXaNNASFAHatltRuzkDDKng1XKJza0MQuo-H5l-t8d88w1UTjJZamfhF-vR5S_aNbVBfFGa6z01XSk1z-hpJPy-hBLXIJseylm7OAP4W0f9sw402w2tCyia3xAXrExGLxdKuUjLs=\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/humacyte-inc-loss-submission-form\/?id=122772&amp;from=3<\/a>\n      <\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>May 10, 2024 to October 17, 2024<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) the FDA\u2019s review of the biologics license application would be delayed while Humacyte remediated these deficiencies; and (3) as a result, there was a substantial risk to FDA approval of acellular tissue engineered vessel for vascular trauma; and (4) as a result of the foregoing, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p>\n        <strong>DEADLINE: January 17, 2025<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sLN1IUrCXah2TvTl3VPsqkVuaA39NVzfNS8IRv17Bfl2435Hs_8LhekEokDgpZh7T2JYMcHyQkGEK4kBz8dFzjbytcVr8Miozz128rhY9jfoW5TBIpbixXf7NlpCRC2OIsz0vvM_m-IzHyWs4EwITXlbu5GEFtwo6LpNGhwAQncu5XMpJIkj1XwlwA9k7YL-DIAoH9Wj5gpl9bpu6U_fUf45HjU5nchSdaEE2E93uTskao77mewKi_pL-rwMstCrg30kblz5C7FGyRcStMs_skgqebus2ID1CJKVlSpNZ9o=\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/humacyte-inc-loss-submission-form\/?id=122772&amp;from=3<\/a><\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of HUMA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is January 17, 2025. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8GS-7sMhRrdqKQ3EWBLmH4QbIbA82PFML68xxl9lT1DWkvTejdabe38jb3nwXjd8SUYaM93RibEaIN0DPoYfn4y5siky2NRfdQxBYnsiVLhf2JXVuiHmT6LrZiVowJyI\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTVlNTE0MTAtNzE5Ni00NzU5LTlmZmQtNWNjZDg0OWNhYmMyLTEyNzA0Njc=\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Humacyte, Inc. (NASDAQ: HUMA). Shareholders who purchased shares of HUMA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/humacyte-inc-loss-submission-form\/?id=122772&amp;from=3 CLASS PERIOD: May 10, 2024 to October 17, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) the FDA\u2019s review of the biologics license application &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-801174","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Humacyte, Inc. (NASDAQ: HUMA). Shareholders who purchased shares of HUMA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/humacyte-inc-loss-submission-form\/?id=122772&amp;from=3 CLASS PERIOD: May 10, 2024 to October 17, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) the FDA\u2019s review of the biologics license application &hellip; Continue reading &quot;The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T17:48:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA\",\"datePublished\":\"2025-01-15T17:48:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/\"},\"wordCount\":412,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/\",\"name\":\"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=\",\"datePublished\":\"2025-01-15T17:48:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/","og_locale":"en_US","og_type":"article","og_title":"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA - Market Newsdesk","og_description":"NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Humacyte, Inc. (NASDAQ: HUMA). Shareholders who purchased shares of HUMA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/humacyte-inc-loss-submission-form\/?id=122772&amp;from=3 CLASS PERIOD: May 10, 2024 to October 17, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company\u2019s Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) the FDA\u2019s review of the biologics license application &hellip; Continue reading \"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-15T17:48:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA","datePublished":"2025-01-15T17:48:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/"},"wordCount":412,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/","name":"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=","datePublished":"2025-01-15T17:48:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjIwNSM2Njk0Mjc4IzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-humacyte-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-17-2025-huma-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 &#8211; HUMA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=801174"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801174\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=801174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=801174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=801174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}